<VariationArchive VariationID="11984" VariationName="NC_000009.11:g.(?_6620184)_(6645307_?)del" VariationType="Deletion" Accession="VCV000011984" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2013-04-04" MostRecentSubmission="2023-06-03">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27023" VariationID="11984">
      <GeneList>
        <Gene Symbol="GLDC" FullName="glycine decarboxylase" GeneID="2731" HGNC_ID="HGNC:4313" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="6532467" stop="6645729" display_start="6532467" display_stop="6645729" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="6532463" stop="6645691" display_start="6532463" display_stop="6645691" Strand="-" />
          </Location>
          <OMIM>238300</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000009.11:g.(?_6620184)_(6645307_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" forDisplay="true" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" innerStart="6620184" innerStop="6645307" display_start="6620184" display_stop="6645307" variantLength="25124" />
      </Location>
      <OtherNameList>
        <Name>30-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.(?_6620184)_(6645307_?)del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.(?_6620184)_(6645307_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="GLDC_000008" DB="LOVD 3" />
        <XRef Type="Allelic variant" ID="238300.0003" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000009.11:g.(?_6620184)_(6645307_?)del AND Glycine encephalopathy 1" Accession="RCV004566731" Version="1">
        <ClassifiedConditionList TraitSetID="93542">
          <ClassifiedCondition DB="MedGen" ID="CN376801">Glycine encephalopathy 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2000-03-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2000-03-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-04-04" MostRecentSubmission="2023-06-03">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10798358</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="93542" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="73004" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glycine encephalopathy 1</ElementValue>
                <XRef ID="MONDO:0958179" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GCE1</ElementValue>
                <XRef Type="MIM" ID="605899" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301531</ID>
                <ID Source="BookShelf">NBK1357</ID>
              </Citation>
              <XRef ID="CN376801" DB="MedGen" />
              <XRef ID="MONDO:0958179" DB="MONDO" />
              <XRef Type="MIM" ID="605899" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32999" SubmissionDate="2010-08-04" DateLastUpdated="2023-06-03" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="238300.0003_GLYCINE ENCEPHALOPATHY 1" title="GLDC, 30-KB DEL_GLYCINE ENCEPHALOPATHY 1" />
        <ClinVarAccession Accession="SCV000032999" DateUpdated="2023-06-03" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2000-03-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Takayanagi et al. (2000) studied a Japanese boy with glycine encephalopathy (GCE1; 605899) of neonatal onset. The parents were not known to be related and were from the Aichi prefecture in the central area of Japan. Convulsive seizures and respiratory distress developed at 3 days of age. Administration of ketamine improved his electroencephalographic findings and hyperirritability. His psychomotor development was, however, severely delayed. He never gained head control or walked, and joint contractures developed. At 9 years of age he died of influenzal pneumonia and renal failure. An enzymatic analysis of an autopsied liver specimen revealed that he was completely deficient in GLDC activity. Takayanagi et al. (2000) found that exons 1-3 of the functional GLDC gene from this patient were not amplified by PCR, whereas those from control subjects were. These results suggested a large homozygous deletion (at least 30 kb) in the patient. Takayanagi et al. (2000) devised a semiquantitative PCR to estimate the number of GLDC alleles by using the pseudogene as an internal control and confirmed the homozygosity and heterozygosity of the deletion in the patient and his parents, respectively.</Attribute>
              <Citation>
                <ID Source="PubMed">10798358</ID>
              </Citation>
              <XRef DB="OMIM" ID="605899" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLDC" />
          </GeneList>
          <Name>GLDC, 30-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">30-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="238300.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GLYCINE ENCEPHALOPATHY 1</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32999" TraitType="Disease" MappingType="Name" MappingValue="GLYCINE ENCEPHALOPATHY 1" MappingRef="Preferred">
        <MedGen CUI="CN376801" Name="Glycine encephalopathy 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

